Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Update

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 1,700 shares, a decrease of 82.3% from the March 31st total of 9,600 shares. Based on an average daily trading volume, of 4,100 shares, the days-to-cover ratio is presently 0.4 days.

Relief Therapeutics Price Performance

OTCMKTS:RLFTF remained flat at $1.45 during trading hours on Friday. The company had a trading volume of 425 shares, compared to its average volume of 2,789. The firm has a fifty day moving average of $1.59 and a 200 day moving average of $1.95. Relief Therapeutics has a 1-year low of $1.20 and a 1-year high of $9.00.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.